ADAMTS15 and prostate cancer: In human prostate cancer, it has been observed that ADAMTS-15 was expressed in biopsies, with evidence of co-localization with VCAN and its bioactive cleavage fragment, versikine, suggesting a tumor suppressor role for ADAMTS-15 in prostate cancer [11].